TAE Technologies, UKAEA Advance Development of Core Fusion Technology

TAE Technologies, a US-based fusion energy company, and the UK Atomic Energy Authority (UKAEA) have launched TAE Beam UK, a fully funded joint venture dedicated to commercializing neutral beam technology. The venture, established in the UK, marks the next phase in their 2025 partnership, combining TAE’s two decades of patented research and UKAEA’s expertise in fusion systems, including the Joint European Torus (JET). Operating from UKAEA’s Culham Campus, TAE Beam UK will focus on developing neutral beams, essential for heating and sustaining fusion reactions. These beams are a core component of TAE’s streamlined power plant design, which the company claims is smaller, more efficient, and cost-effective than other fusion approaches. Beyond fusion, the technology has applications in food safety, homeland security, and non-invasive cancer treatment through TAE’s biotech subsidiary, TAE Life Sciences. Michl Binderbauer, CEO of TAE Technologies, emphasized that neutral beams are key to achieving commercial fusion power, supporting both TAE’s first power plant and broader fusion advancements. Tim Bestwick, CEO of UKAEA, highlighted the venture as a major step toward commercialization. The partnership leverages UKAEA’s 40-year legacy in fusion research and TAE’s industry-leading neutral beam expertise to accelerate clean energy solutions. TAE Beam UK’s work will begin immediately, aiming to make the technology available for various fusion configurations and non-fusion industries. The collaboration underscores the growing global effort to bring fusion energy to the grid as a cost-competitive and sustainable alternative.